Abstract
Multiple sclerosis (MS) is a chronic inflammatory and autoimmune disease characterized by demyelination of the central nervous system (CNS). Neuregulin 1 (NRG1) is a signaling protein that plays an important role in a variety of biological processes, including potentiate oligodendrocyte differentiation and myelination in the CNS, immune response regulation, and inflammation. Single nucleotide polymorphism (SNP) rs77493513 is located in the untranslated region of the 3' mRNA (3'-UTR) of the NRG1 gene, which is predicted to be the binding site of several microRNAs and may play an important role in post-transcriptional regulation. Study aimed to investigate the association of SNP rs77493513 in the NRG1 gene with the risk of MS disease. In this study, genomic DNA was extracted from whole blood samples of 182 patients with relapsing-remitting multiple sclerosis (RRMS) and 198 controls. Different genotypes of rs77493513 polymorphism were determined using RFLP-PCR technique. Statistical analysis was performed using SPSS 21.0 software and by t, χ2 and logistic regression tests. Our data showed that genotypes AC (OR=3.63, CI= 1.93-6.81, p<0.001) and CC (OR=7.90, CI= 4.13-15.11, p<0.001) significantly increased the risk of MS disease and C allele is risk allele. Also, AC (OR=0.16, CI= 0.04-0.63, p= 0.009) and CC (OR=0.14, CI= 0.03-0.53, p=0.04) genotypes significantly decrease the age of onset of the disease. The results show that allele C of rs77493513 polymorphism in the NRG1 gene can be a risk factor for MS.
Similar content being viewed by others
References
Assinck P, Duncan GJ, Plemel JR, Lee MJ, Stratton JA, Manesh SB et al (2017) Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury. J Neurosci 37:8635–8654
Bahadori Z, Behmanesh M, Sahraian MA (2015) Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis. J Neuro Sci 351:154–159
Bhatheja K, Field J (2006) Schwann cells: origins and role in axonal maintenance and regeneration. Int J Biochem 38:1995–1999
Birchmeier C, Bennett DL (2016) Neuregulin/ErbB signaling in developmental myelin formation and nerve repair. Cur Top Dev Biol 116:45–64
Birchmeier C, Nave KA (2008) Neureguli-1, a key axonal siganl that drives schwann cell growth and differentiation. Glia 56:1491–1497
Browne P, Chandraratna D, Angood C, Tremlett H, Bacher C, Taylor BV et al (2014) Atlas of Multiple sclerosis 2013: A growing global problem with widespread inequity. Neurology 83:1022–1024
Cai Y, Yu X, Hu S, Yu J (2009) A brief review on the mechanisms of miRNA regulation. Genomics proteomics bioinformatics 7:147–154
Catalanotto C, Cogoni C, Zardo G (2016) MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci 17:1712
Dehghanzad R, Pahlevan Kakhki M, Alikhah A, Sahraian MA, Behmanesh M (2020) The putative association of TOB1-AS1 long non-coding RNA with immune tolerance: A study on multiple sclerosis patients. Neuromolecular Med 22:100–110
Dehghanzad R, Panahi Moghadam S, Shirvani Farsani Z (2021) Prediction of Single-Nucleotide Polymorphisms within microRNAs Binding Sites of Neuronal Genes Related to Multiple Sclerosis: A Preliminary Study. Adv Biomed Res 10:8
Garcia-Diaz B, Baron-van Evercooren A (2020) Schwann cells: Rescuers of central demyelination. Glia 68:1945–1956
Guo L, Chen F (2014) A challenge for miRNA: multiple isomiRs in miRNAomics. Gene 544:1–7
Kataria H, Alizadeh A, Shahriary GM, Saboktagin RS, Henrie R, Santhosh KT et al (2017) Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammtory response in focal demyelinating lesions of the spinal cord. Glia 66:531–568
Kozomara A, Griffiths-Jones S (2011) miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:152–157
Kremer D, Akkermann R, Küry P, Dutta R (2019) Current advancements in promoting remyelination in multiple sclerosis. Mult Scler J 25:7–14
Kruger J, Rehmsmeier M (2006) RNAhybrid: MicroRNA target prediction easy, fast and flexible. Nucleic Acids Res 34:451–454
Liu CH-J, Fu X, Xia M, Zhang Q, Gu Z, Guo A-Y (2021) miRNASNP-v3: a comprehensive database for SNPs and disease-related variations in miRNAs and miRNA targets. Nucleic Acids Research 49:1276–1281
Loeb JA (2007) Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis. Neurology 68:S38–S42
Lopez-Ramirez MA, Wu D, Pryce G et al (2014) MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. Faseb J 28:2551–2565
Ma D, Wang B, Zawadzka M, Gonzalez G, Wu Z, Yu B et al (2018) A Subpopulation of Foxj1-Expressing, Nonmyelinating Schwann Cells of the Peripheral Nervous System Contribute to Schwann Cell Remyelination in the Central Nervous System. J Neurosci 38:9228–9239
Manikandan M, Munirajan AK (2014) Single Nucleotide Polymorphisms in MicroRNA Binding Sites of Oncogenes: Implications in Cancer and Pharmacogenomics. OMICS: A Journal of. Integrative Biology. 18:142–154
Meijer H, Kong Y, Lu W, Wilczynska A, Spriggs R, Robinson S et al (2013) Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 340:82–85
Miller DH, Leary SM (2007) Primary-progressive multiple sclerosis. Lancet Neurol 6:903–912
Moszyńska A, Gebert M, Collawn JF, Bartoszewski R (2017) SNPs in microRNA target sites and their potential role in human disease. Open Biol 7:1–12
Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468:244–252
Oh J, Vidal-Jordana A, Montalban X (2018) Multiple sclerosis: clinical aspects. Curr Opin Neurol 31:752–759
Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T et al (2016) Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e267
Rostami Mansoor S, Ghasemi-Kasman M, Yavarpour-Bali H (2020) The role of microRNAs in multiple sclerosis. Int Rev Immunol 30:1–15
Teuber-Hanselmann S, Meinl E, Junker A (2020) MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology. J Pathol 250:496–509
Tripathi A, Volsko C, Datta U et al (2019) Expression of disease-related miRNAs in white-matter lesions of progressive multiple sclerosis brains. Ann Clin Transl Neurol 6:854–862
Vuokila N, Lukasiuk K, Bot AM et al (2018) miR-124-3p is a chronic regulator of gene expression after brain injury. Cell. Mol. Life Sci. 75:4557–4581
Wang Z, Colognato H, Ffrench-Constant C (2007) Contrasting effects of mitogenic growth factors on myelination in neuron-oligodendrocyte co-cultures. Glia 55:537–545
Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F et al (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6:578–590
Zhang H, Jarjour AA, Boyd A, Williams A (2011) Central nervous system remyelination in culture—a tool for multiple sclerosis research. Exp neurol 230:138–148
Acknowledgment
Our special thanks to the nurses in the Neurology Division of AL-Zahra Hospital for their cooperation with regard to sampling.
Availability of data and material
Not applicable
Code availability
Not applicable
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Maedeh Ghorbani participated to sample preparation and carried out the experiments. Parisa Mohamadynejad designed, planned, supervised the project and wrote the manuscript. Mehdi Moghanibashi advised and helped to the interpretation of the results and write the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest.
Ethics approval
The Institutional Review Board of the Islamic Azad University, Shahrekord Branch approved the study protocol.
Consent to participate
The informed consent forms were obtained from the participants.
Consent for publication
All authors discussed the results and commented on the manuscript. Neither the article nor portions of it have been previously published elsewhere. The manuscript is not under consideration for publication in another journal, and will not be submitted elsewhere until the “Metabolic Brain Disease” editorial process is completed, and all authors consent to the publication of the manuscript in “Metabolic Brain Disease”.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ghorbani, M., Mohamadynejad, P. & Moghanibashi, M. Significant Association of rs77493513 Polymorphism in 3'-UTR of the NRG1 Gene with the Risk of Multiple Sclerosis Disease. Metab Brain Dis 37, 1025–1030 (2022). https://doi.org/10.1007/s11011-022-00922-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-00922-9